CBD-Intel

Regulatory alerts roundup

CBD-Intel regulatory news in brief, 3rd-9th March

Written by || 9th March 2020 || Regulatory alerts roundup | Regulation and Legislation | Colombia Europe Germany Hawaii Idaho Louisiana Luxemburg North America Ohio Slovenia South America United States

This week's regulatory news in brief brings updates from the US, Colombia, Germany, Slovenia and Luxembourg ...

Restricted content. Do you want to read more?

Read related content from CBD-Intel

EIHA statement leads to confusion over Germany’s novel food position
Upcoming legislation set to propel Colombian CBD industry development
US FDA chief Hahn says it would be ‘a fool’s game’ to try to halt CBD spread

Featured topic

The Food and Drug Administration (FDA) rejected applications to use hemp extract as a dietary supplement.

Here are the conclusions we have attracted. CBD-Intel will continue to work on providing answers to the various questions that have arisen.

Blog | Policy and politics | US federal regulation

Sign up to our newsletter

By signing up you agree to our Terms and Conditions